4:55 PM
 | 
Aug 27, 2013
 |  BC Extra  |  Top Story

Syndax raises $26.6 million in series B

Cancer company Syndax Pharmaceuticals Inc. (Waltham, Mass.) raised $26.6 million in a series B round from existing investors Domain Associates; MPM Capital; and Forward Ventures as well as new investor Rusnano. Rusnano's...

Read the full 144 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >